| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Actions of PAF in the rat anterior pituitary
|
Grandison, L.
|
|
|
34 |
2 |
p. 177
|
artikel
|
| 2 |
Activation of suppressor lymphocytes and monocytes by PAF-acether
|
Rola-Pleszczynski, M.
|
|
|
34 |
2 |
p. 148
|
artikel
|
| 3 |
Acute pulmonary and cardiovascular effects of platelet-activating factor in man: Relevance in anaphylactic shock
|
Gateau, O.
|
|
|
34 |
2 |
p. 182
|
artikel
|
| 4 |
A model for PAF activity in the allergic rabbit: Modification of the late asthmatic response and bronchial hyperreactivity by PAF antagonist, BN 52021
|
Metzger, W.J.
|
|
|
34 |
2 |
p. 181
|
artikel
|
| 5 |
Antagonist affinities for PAF receptors differentially depend on the degree of macrophage activation
|
Bittner, C.
|
|
|
34 |
2 |
p. 175
|
artikel
|
| 6 |
Arachidonic acid metabolism in alveolar macrophages. A comparison of cells from healthy subjects, allergic asthmatics, and chronic bronchitis patients
|
Damon, M.
|
|
|
34 |
2 |
p. 291-309
|
artikel
|
| 7 |
Arterial wall-blood cell response to PAF-acether
|
Bourgain, R.H.
|
|
|
34 |
2 |
p. 165
|
artikel
|
| 8 |
Author index
|
|
|
|
34 |
2 |
p. 332-334
|
artikel
|
| 9 |
Azathioprine-induced in vitro inhibition of prostaglandin E2 production by rabbit retina
|
Dottan, S.
|
|
|
34 |
2 |
p. 271-277
|
artikel
|
| 10 |
Clinical evidences for the role of PAF-acether in airway hyperreactivity and asthma
|
Guinot, P.
|
|
|
34 |
2 |
p. 184
|
artikel
|
| 11 |
Comparison of the eosinophilotactic effect of PAF-acether and antigen in vivo: role of PAF-acther antagonist and platelets
|
Lellouch-Tubiana, A.
|
|
|
34 |
2 |
p. 168
|
artikel
|
| 12 |
Contribution of PAF to anaphylactic response of guinea-pig heart is to increase coronary arterial resistance
|
Zor, U.
|
|
|
34 |
2 |
p. 194
|
artikel
|
| 13 |
Development and application of a quantitative immunoassay for PAF
|
Baldo, B.A.
|
|
|
34 |
2 |
p. 195
|
artikel
|
| 14 |
Differential effect of platelet-activating factor receptor antagonists on human T-lymphocyte proliferation
|
Ward, S.G.
|
|
|
34 |
2 |
p. 149
|
artikel
|
| 15 |
Effect of long-term treatment with platelet-activating factor (PAF-acether) on interleukin-1 (IL1) and interleukin-2 (IL2) production in the rat
|
Pignol, B.
|
|
|
34 |
2 |
p. 150
|
artikel
|
| 16 |
Effect of PAF-acether (platelet-activating factor) and its specific antagonist, BN 52021, on interluekin 1 (IL1) synthesis and release by rat monocytes
|
Mencia-Huerta, J.M.
|
|
|
34 |
2 |
p. 152
|
artikel
|
| 17 |
Effect of PAF and inhibitors in the natural killer cell-mediated cytotoxic reaction
|
Bonavida, B.
|
|
|
34 |
2 |
p. 157
|
artikel
|
| 18 |
Effect of PAF and its antagonists on preformed mediator secretion from mast cells
|
Stanworth, D.R.
|
|
|
34 |
2 |
p. 170
|
artikel
|
| 19 |
Effect of PAF on B on T cell proliferation
|
Behrens, T.
|
|
|
34 |
2 |
p. 154
|
artikel
|
| 20 |
Endothelial cells and inflammation: The role of PAF, monokines and circulating cells
|
Bussolino, F.
|
|
|
34 |
2 |
p. 172
|
artikel
|
| 21 |
Ether-lipids and cell immunity. A potential role for antitumor activity
|
Andreesen, R.
|
|
|
34 |
2 |
p. 161
|
artikel
|
| 22 |
FAP activates rat macrophages and enhances complement-mediateed phagocytes
|
Turrini, F.
|
|
|
34 |
2 |
p. 174
|
artikel
|
| 23 |
Functional and morphologic alterations of guinea-pig lung induced by chronic infusion of platelet-activating factor (PAF-acether) support a role for the mediator in bronchial hyperreactivity
|
Touvay, C.
|
|
|
34 |
2 |
p. 180
|
artikel
|
| 24 |
Further characterisation of platelet-activating factor-induced IL1 production by human adherent monocytes
|
Ward, S.G.
|
|
|
34 |
2 |
p. 151
|
artikel
|
| 25 |
Ginkgolide B (BN 52021) and cardiac anaphylaxis
|
Koltai, M.
|
|
|
34 |
2 |
p. 187
|
artikel
|
| 26 |
Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis
|
Wallace, John L.
|
|
|
34 |
2 |
p. 311-323
|
artikel
|
| 27 |
Involvement of PAF-acether in acute immune-complex induced pancreatitis
|
Jancar, S.
|
|
|
34 |
2 |
p. 192
|
artikel
|
| 28 |
List of contents of PAF meeting
|
|
|
|
34 |
2 |
p. 325-328
|
artikel
|
| 29 |
MHC in central nervous system: modulation of expression by PAF-acether
|
Martin-Mondière, C.
|
|
|
34 |
2 |
p. 163
|
artikel
|
| 30 |
Nomenclature of lipoxins and related compounds derived from arachidonic acid and eicosapentaenoic acid
|
Serhan, Charles N.
|
|
|
34 |
2 |
p. 201-204
|
artikel
|
| 31 |
PAF-acether and natural killer cells
|
Mándi, Y.
|
|
|
34 |
2 |
p. 155
|
artikel
|
| 32 |
PAF-acether: A possible mediator of autoimmune diseases
|
Wilcox, C.E.
|
|
|
34 |
2 |
p. 164
|
artikel
|
| 33 |
PAF-acether augments human natural killer cell activity
|
Rola-Pleszczynski, M.
|
|
|
34 |
2 |
p. 156
|
artikel
|
| 34 |
PAF-acether-induced membrane ion movements in the triggering of the immune cell functions
|
Garay, R.P.
|
|
|
34 |
2 |
p. 162
|
artikel
|
| 35 |
PAF-acether in immediate pulmonary hypersensitivity
|
Bachelet, M.
|
|
|
34 |
2 |
p. 179
|
artikel
|
| 36 |
PAF-acether mediates the fibrinolysis, but not the thrombocytopenia induced by immunoglobulin aggregates (A-IgG)
|
Fernandez-Gallardo, S.
|
|
|
34 |
2 |
p. 193
|
artikel
|
| 37 |
PAF and asthma
|
Barnes, P.
|
|
|
34 |
2 |
p. 183
|
artikel
|
| 38 |
PAF and transplant immunology
|
Foegh, M.
|
|
|
34 |
2 |
p. 186
|
artikel
|
| 39 |
PAF as a facilitator of the immune response: Its role in priming inflammatory and endothelial cells
|
Jacob, H.S.
|
|
|
34 |
2 |
p. 171
|
artikel
|
| 40 |
PAF as a modulator of neuropeptide secretions: A link with the immune response
|
Dray, F.
|
|
|
34 |
2 |
p. 176
|
artikel
|
| 41 |
PAF-mediated leukotriene biosynthesis in lungs : Control by the neuropeptidergic system
|
Di Marzo, V.
|
|
|
34 |
2 |
p. 185
|
artikel
|
| 42 |
PAF-related analogues and their interaction with immunocomponent cells
|
Munder, P.G.
|
|
|
34 |
2 |
p. 160
|
artikel
|
| 43 |
Platelet - activating factor induces leukotriene C4 synthesis by purified human eosinophils
|
Bruijnzeel, Pieter L.B.
|
|
|
34 |
2 |
p. 205-214
|
artikel
|
| 44 |
Platelet-activating factor (PAF) effects on endothelial cells
|
Ryan, U.S.
|
|
|
34 |
2 |
p. 173
|
artikel
|
| 45 |
Potentiation of the effect of BN 5201, a PAF antagonist by cyclosporine a (CsA) in the cerebral post ischemic phase in gerbils
|
Spinnewyn, B.
|
|
|
34 |
2 |
p. 197
|
artikel
|
| 46 |
Potentiation of the effect of cyclosporine a (CsA) by BN 52021, a platelet-activating factor (PAF) antagonist on forced swimming-induced behavioral despair in mice
|
Clostre, F.
|
|
|
34 |
2 |
p. 199
|
artikel
|
| 47 |
Potentiation of the immunosuppressive action of cyclosporine a (CsA) by PAF antagonists: An approach of the mechanism of action
|
Braquet, P.
|
|
|
34 |
2 |
p. 198
|
artikel
|
| 48 |
Prostaglandin F2 stimulates the generation of lipoxygenase products in gunia pig isolated trachea
|
Shikada, K.
|
|
|
34 |
2 |
p. 215-224
|
artikel
|
| 49 |
Prostaglandin G2 levels during reaction of prostaglandin H synthase with arachidonic acid
|
Kulmacz, Richard J.
|
|
|
34 |
2 |
p. 225-240
|
artikel
|
| 50 |
Recovery of prostacyclin capacity of irradiated endothelial cells and the protective effect of vitamin C
|
Eldor, A.
|
|
|
34 |
2 |
p. 241-255
|
artikel
|
| 51 |
Regulation of Candida albicans killing activity of human epidermal cells
|
Dobozy, A.
|
|
|
34 |
2 |
p. 159
|
artikel
|
| 52 |
Release of immunoreactive substance P (SP) and vasointestinal peptide (VIP) form guinea-pig upper airways by platelet-activating factor (PAF-ACETHER)
|
Rodrigue, F.
|
|
|
34 |
2 |
p. 178
|
artikel
|
| 53 |
Role of PAF-acether in IgE-dependent activation of eosinophils
|
Capron, M.
|
|
|
34 |
2 |
p. 167
|
artikel
|
| 54 |
Role of PAF in the splenic lymphocyte-induced impairment of Langerhans islets
|
Farkas, G.
|
|
|
34 |
2 |
p. 158
|
artikel
|
| 55 |
Stimulatory and inhibitory effects of prostaglandins on the gonadotropin-sensitive adenylate cyclase in the monkey corpus luteum
|
Molskness, T.A.
|
|
|
34 |
2 |
p. 279-290
|
artikel
|
| 56 |
Subject index PAF meeting
|
|
|
|
34 |
2 |
p. 329-331
|
artikel
|
| 57 |
Synergistic effect of platelet-activating factor (PAF) antagonist with cyclosporine a in PAF-induced bronchoconstriction in guinea-pigs
|
Touvay, C.
|
|
|
34 |
2 |
p. 196
|
artikel
|
| 58 |
The effect of acetylsalicylic acid and indomethacin on the catecholamine- and oxytocin-induced cotractility and prostaglandin (6-keto-PGF1a, PGF2a)-production of human pregnant myometrial strips
|
Quaas, L.
|
|
|
34 |
2 |
p. 257-269
|
artikel
|
| 59 |
The effect of platelet-activating factor on cellular immune reactions in vitro
|
Gebhardt, B.M.
|
|
|
34 |
2 |
p. 153
|
artikel
|
| 60 |
The effect of the platelet-activating factor antagonist BN 52021 on the hyperglycemia indcued by alloxan
|
Egido, J.
|
|
|
34 |
2 |
p. 188
|
artikel
|
| 61 |
The role of PAF in antigen-induced eosinophil accumulation in the lung
|
Coyle, A.J.
|
|
|
34 |
2 |
p. 169
|
artikel
|
| 62 |
The role of PAF in eosinophil and neutrophil activation and locomotion
|
Wardlaw, A.
|
|
|
34 |
2 |
p. 166
|
artikel
|
| 63 |
The role of PAF in immunological responses: A review
|
Braquet, P.
|
|
|
34 |
2 |
p. 143-147
|
artikel
|
| 64 |
The role of PAF in kidney immune disorders
|
Egido, J.
|
|
|
34 |
2 |
p. 189
|
artikel
|
| 65 |
Unbalance between production and catabolism of platelet-activating factor (PAF) in human pathology. Studies of PAF acetylhydrolase (AH) in systemic lupus erythematosus (SLE)
|
Tetta, C.
|
|
|
34 |
2 |
p. 190
|
artikel
|
| 66 |
Whole blood and the effect of administering BN 52063 to man
|
Bevan, J.
|
|
|
34 |
2 |
p. 191
|
artikel
|
| 67 |
1988 Winter prostaglandin conference Keystone, Colorado
|
|
|
|
34 |
2 |
p. 141
|
artikel
|
Tijdschrift beschrijving